JAGSNPHARM

Jagsonpal Pharmaceuticals News

₹227.25-3.46%close, 9 Oct 2026
Market cap
₹1,522 crore
P/E
22.5
P/B
2.85
ROE
14.5%
Dividend yield
1.20%
52-week range
₹163.62 – ₹306.79

The latest update on Jagsonpal Pharmaceuticals is "Jagsonpal Pharmaceuticals Limited Reports Operational Performance & Quarterly Growth Update" (BSE Corporate Announcement), published 9 October 2026. This page lists 4 recent headlines and exchange announcements, 2 of them filed on BSE. Jagsonpal Pharmaceuticals' next board meeting for results is scheduled for 3 November 2026.

Latest Jagsonpal Pharmaceuticals news and announcements

Next results board meeting: 3 November 2026.

  1. Jagsonpal Pharmaceuticals Limited Reports Operational Performance & Quarterly Growth UpdateResults BSE Corporate Announcement · 9 Oct 2026
  2. Market Activity: Jagsonpal Pharmaceuticals Limited Shares See Strong Institutional VolumeNews Economic Times · 8 Oct 2026
  3. Jagsonpal Pharmaceuticals Limited Board Compliances & Mandatory Disclosure Filings SubmittedExchange filing BSE Filings · 7 Oct 2026
  4. Analyst Review: Key Valuation Overview & Target Projection for Jagsonpal Pharmaceuticals LimitedNews Financial Express · 5 Oct 2026

Source: Publisher headlines and announcements filed on BSE, linked to their original sources. Data as of 9 October 2026. How this data is compiled.

Jagsonpal Pharmaceuticals news & announcements — frequently asked questions

What is the latest news on Jagsonpal Pharmaceuticals?

The most recent item is "Jagsonpal Pharmaceuticals Limited Reports Operational Performance & Quarterly Growth Update" from BSE Corporate Announcement on 9 October 2026. The full list above links to each original source.

When are Jagsonpal Pharmaceuticals' next results?

Jagsonpal Pharmaceuticals has announced a board meeting on 3 November 2026 to consider its financial results, according to its filing on BSE.

Where do these Jagsonpal Pharmaceuticals headlines come from?

Headlines link to the original publisher, and exchange announcements link to the filing on BSE. ATS lists them by date and does not rewrite or summarise them.

Same Data For Peers

Trade Jagsonpal Pharmaceuticals With ATS

Track JAGSNPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.